Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Gabriel Moreno

14 indexed publications match this author name.

ORCID: 0000-0002-9303-7181
OpenAlex: https://openalex.org/A5050104617

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 7 Receptor Pharmacology 7 Review Article 5 OCD 4 Mechanism of Action 4 Animal Study 4 Anxiety 3 Adverse Events 3 Toxicity 3 Chronic Pain 3 Wellbeing 2 Consciousness 2

Journals

Frontiers in Psychiatry 1 ClinicalTrials.gov 1 Journal of Psychopharmacology 1 Clinical Neuropharmacology 1 Letters in Applied NanoBioScience 1 Forensic Chemistry 1 European Neuropsychopharmacology 1 Journal of Neuroscience 1

Publication history

Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilizationFrontiers in Psychiatry · 2026-05-12 A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.ClinicalTrials.gov · 2026-05-11 A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorderJournal of Psychopharmacology · 2026-03-12 Psilocybin Use in the Autism Spectrum Disorder: A Scoping ReviewClinical Neuropharmacology · 2025-08-31 A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Unknown journal · 2025-02-26 Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.Unknown journal · 2022-10-31 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16 Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-07 Psilocybin for the Treatment of Obsessive-Compulsive Disorders.Unknown journal · 2021-12-31 P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30 Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.Unknown journal · 2013-01-15 Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.Journal of Neuroscience · 2011-01-31 Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.Unknown journal · 2011-01-26 Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.The Journal of Clinical Psychiatry · 2006-10-31

Author directory